Does ischemia-modified albumin add prognostic value to the Thrombolysis in Myocardial Infarction risk score in patients with ST-segment elevation myocardial infarction treated with primary angioplasty?

Biomarkers

Volumn 14, Issue 1, 2009, Pages 43-48

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Jimenez Sosa, Alejandro ^a   Samimi Fard, Sima ^a   Idaira, Hernandez Baldomero ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Ischaemia modified albumin; Primary percutaneous coronary intervention; ST segment elevation myocardial infarction; TIMI risk score

Indexed keywords

ISCHEMIA MODIFIED ALBUMIN; ALBUMINOID;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; ST SEGMENT ELEVATION; ELECTROCARDIOGRAPHY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; ROC CURVE;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; ANGIOPLASTY; ELECTROCARDIOGRAPHY; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; ROC CURVE;

EID: 66149155460     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500802706020     Document Type: Article

References (16)

1. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E. (2000). The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284:835-842.
2. Aparci M, Kardesoglu E, Ozmen N, Ozcan O, Cebeci BS, Cingozbay BY, Dincturk M. (2007). Prognostic significance of ischemia-modified albumin in patients with coronary syndrome. Coron Artery Dis 18:367-373.
3. Bar-Or D, Lau E, Winkler JV. (2000). A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med 19:311-315.
4. Bar-Or D, Rael LT, Bar-Or R, Slone DS, Mains CW, Rao NKR, Curtis CG. (2008). The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta 387:120-127.
5. Consuegra-Sanchez L, Bouzas-Mosquera A, Sinha MK, Collinson PO, Gaze DC, Kaski JC. (2008). Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemia chest pain. Heart Vessels 23:174-180.
6. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Samimi-Fard S, Kaski JC. (2008). Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Clin Chim Acta 388:196-199.
7. Dominguez-Rodriguez A, Kaski JC, Abreu-Gonzalez P, Samimi-Fard S. (2008). Role of ischemia modified albumin to ST-segment resolution after mechanical reperfusion in patients with ST-segment elevation myocardial infarction. Atherosclerosis doi:10.1016/j. atherosclerosis.2008.07.033.
8. Garrido IP, Roy D, Calvino R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J, Quiles J, Gaze DC, Kaski JC. (2004). Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol 93:88-90.
9. Killip T, Kimball JT. (1967). Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20:457-464.
10. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. (2000). TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102:2031-2037.
11. Quiles J, Roy D, Gaze D, Garrido IP, Avanzas P, Sinha M, Kaski JC. (2003). Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 92:322-324.
12. Roy D, Quiles J, Gaze DC, Collinson PO, Kaski JC, Baxter GF. (2006). Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 92:113-114.
13. Roy D, Quiles J, Sinha M, Aldama G, Gaze D, Kaski JC. (2004). Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol 93:366-368.
14. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. (2003). Ischemia modified albumin is a sensitive marker of ischemia after percutaneous coronary intervention. Circulation 107:2403-2405.
15. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. (2004). Role of 'ischemia modified albumin', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21:29-34.
16. Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J, Mookadam F, Hill SA. (2005). Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 172:1685-1690.